This week, BioPharmaDispatch is using a series to highlight red flags in the Health Technology Assessment Review report, each contributing to undermining access to medicines and other therapeutic interventions.
The HTA Review report - 'Red Flag' number one of five
September 16, 2024 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Australians fear the loss of independence as vision health concerns rise
August 29, 2025 - - Latest News -
NDIS quarterly report presents a positive picture, but questions remain
August 29, 2025 - - Latest News -
Wesfarmers Health delivers growth as Priceline drives consumer momentum
August 29, 2025 - - Latest News -
'We can evade reality, but we cannot evade the consequences of evading reality'
August 29, 2025 - - Latest News -
Government pressed on diabetes inquiry response as obesity costs soar
August 29, 2025 - - Latest News -
Coalition turns debate on cheaper medicines Bill to HTA reform delays
August 27, 2025 - - Latest News -
Pharmacy Guild showcases more accessible healthcare for women
August 27, 2025 - - Latest News